533,466 Shares in Viemed Healthcare, Inc. $VMD Bought by Punch & Associates Investment Management Inc.

Punch & Associates Investment Management Inc. purchased a new stake in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 533,466 shares of the company's stock, valued at approximately $6,082,000. Punch & Associates Investment Management Inc. owned approximately 1.40% of Viemed Healthcare as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. Kemnay Advisory Services Inc. bought a new position in Viemed Healthcare in the fourth quarter worth about $46,000. Quarry LP bought a new stake in Viemed Healthcare during the 3rd quarter valued at approximately $48,000. Globeflex Capital L P purchased a new position in shares of Viemed Healthcare during the 2nd quarter worth approximately $86,000. Legal & General Group Plc bought a new position in shares of Viemed Healthcare in the 2nd quarter worth approximately $97,000. Finally, The Manufacturers Life Insurance Company bought a new position in shares of Viemed Healthcare in the 2nd quarter worth approximately $119,000. 74.24% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

VMD has been the topic of several research reports. Wall Street Zen lowered Viemed Healthcare from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 15th. Weiss Ratings cut shares of Viemed Healthcare from a "buy (b-)" rating to a "hold (c+)" rating in a report on Monday, August 17th. Freedom Capital lowered shares of Viemed Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, August 5th. Finally, Barrington Research started coverage on shares of Viemed Healthcare in a research report on Monday. They set an "outperform" rating and a $14.00 price target for the company. One analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $14.00.

Insider Buying and Selling at Viemed Healthcare

In related news, insider William Frazier sold 10,000 shares of the business's stock in a transaction dated Thursday, June 25th. The stock was sold at an average price of $11.72, for a total value of $117,200.00. Following the sale, the insider directly owned 73,214 shares in the company, valued at approximately $858,068.08. The trade was a 12.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Timothy Smokoff sold 20,000 shares of the company's stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total transaction of $230,000.00. Following the sale, the director directly owned 75,518 shares in the company, valued at approximately $868,457. The trade was a 20.94% decrease in their position. The SEC filing for this sale provides additional information. 20.60% of the stock is owned by insiders.

Viemed Healthcare Stock Up 2.5%

Shares of Viemed Healthcare stock opened at $9.33 on Thursday. The company has a market cap of $355.38 million, a price-to-earnings ratio of 25.92, a price-to-earnings-growth ratio of 2.25 and a beta of 1.10. Viemed Healthcare, Inc. has a twelve month low of $6.05 and a twelve month high of $12.61. The company has a quick ratio of 1.02, a current ratio of 1.13 and a debt-to-equity ratio of 0.04. The company's 50 day moving average is $10.90 and its 200 day moving average is $9.89.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last announced its earnings results on Monday, August 3rd. The company reported $0.07 EPS for the quarter, missing analysts' consensus estimates of $0.12 by ($0.05). The business had revenue of $78.10 million for the quarter, compared to analysts' expectations of $78.00 million. Viemed Healthcare had a net margin of 4.81% and a return on equity of 10.16%. Research analysts anticipate that Viemed Healthcare, Inc. will post 0.41 EPS for the current year.

About Viemed Healthcare

Viemed Healthcare, Inc NASDAQ: VMD is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.

Want to see what other hedge funds are holding VMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source